Investing First patient dosed in Phase IIb imaging for Brain Mets April 28, 2025 Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post RHI: Acqn of royalty over Sandstone Gold Project tenements April 28, 2025 Related Posts Investor Presentation February 10, 2026 Multiple Zones of Visual Copper Mineralisation at Chester February 10, 2026 Rio Tinto and Glencore Walk Away from Mega-Merger, but Mining M&A Marches On February 10, 2026
